Cargando…
Open-label, Randomized Crossover Study Between Telmisartan and Valsartan on Improving Insulin Resistance and Adipocytokines in Nondiabetic Patients with Mild Hypertension
Objective: The comparative effect of telmisartan and valsartan upon insulin resistance and adipocytokines in nondiabetic patients with mild hypertension is unclear. Methods: Fifty nondiabetic patients with untreated mild hypertension were randomly assigned to telmisartan (40 mg/day) and valsartan (8...
Autores principales: | Ohbayashi, Hiroyuki, Minatoguchi, Shinya, Aoyama, Takuma, Fujiwara, Hisayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Association of Rural Medicine
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309358/ https://www.ncbi.nlm.nih.gov/pubmed/25649195 http://dx.doi.org/10.2185/jrm.5.165 |
Ejemplares similares
-
Telmisartan Versus Valsartan in Patients With Hypertension: Effects on Cardiovascular, Metabolic, and Inflammatory Parameters
por: Lim, Sung Yoon, et al.
Publicado: (2011) -
Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012) -
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007) -
Resolution of Hypoglycemia Following Cessation of Sacubitril–Valsartan Combination Therapy in a Nondiabetic Patient
por: Morgan, Georgia, et al.
Publicado: (2022) -
Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)